Anchor Capital Advisors LLC Has $46.83 Million Stock Position in GE HealthCare Technologies Inc. $GEHC

Anchor Capital Advisors LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 632,207 shares of the company’s stock after purchasing an additional 36,580 shares during the quarter. GE HealthCare Technologies makes up about 1.4% of Anchor Capital Advisors LLC’s investment portfolio, making the stock its 20th largest position. Anchor Capital Advisors LLC owned approximately 0.14% of GE HealthCare Technologies worth $46,828,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of GEHC. JPMorgan Chase & Co. raised its position in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the last quarter. Nuveen LLC bought a new position in GE HealthCare Technologies in the 1st quarter valued at $77,058,000. Eminence Capital LP raised its position in GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after purchasing an additional 507,101 shares during the last quarter. Homestead Advisers Corp raised its position in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after purchasing an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board raised its position in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after purchasing an additional 409,636 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 1.8%

Shares of GE HealthCare Technologies stock opened at $75.61 on Thursday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The business has a fifty day simple moving average of $75.12 and a 200 day simple moving average of $73.32. The stock has a market cap of $34.44 billion, a PE ratio of 15.62, a price-to-earnings-growth ratio of 2.79 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same period in the previous year, the firm earned $1.14 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price objective for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Finally, Barclays assumed coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.